Pap Duo-lbc+hpv Dna Detector

The Pap Duo-LBC + HPV DNA Detector is a combination test that uses both Liquid-Based Cytology (LBC) for the Pap smear and HPV DNA detection. The Pap smear detects precancerous or cancerous changes in cervical cells, while the HPV DNA test identifies the presence of high-risk strains of the Human Papillomavirus, which are known to cause cervical cancer.

• Early detection of cervical cancer: It is essential for detecting precancerous changes that can lead to cervical cancer.
• Identification of high-risk HPV strains: Identifying high-risk HPV types helps assess the risk of developing cervical cancer.
• Screening for women with abnormal Pap smears: This combination test provides more comprehensive results, improving the accuracy of cervical cancer screenings.

• Women over 21 years of age should begin screening for cervical cancer with Pap smears, typically every 3 years.
• Women aged 30-65 are recommended to have both Pap smears and HPV testing every 5 years, or just HPV testing every 5 years.
• Women with abnormal Pap smear results, a history of abnormal HPV tests, or those at high risk for cervical cancer (e.g., multiple sexual partners, a weakened immune system, smoking).
• Women who have had abnormal bleeding or discharge.

This test is considered one of the most reliable methods for detecting cervical cancer at an early stage, enabling more effective interventions and improving survival rates. Regular testing reduces cervical cancer mortality significantly.